T. Rowe Price Associates Inc.

Activity from announced rounds

All recorded activity
Rounds participated in
8
Confirmed lead rounds
0
2 roles undisclosed
New companies
7
First participation on record · 1 follow-on
Funding in participating rounds
$81.5B
8 disclosed · full round size, not this investor’s share

By stage

Series C+7
Series B1

By primary sector

AI3
Biotech1
Climate tech1
Enterprise software1
Hardware1
1 more
Healthtech1

By country

United States7
Canada1

Rounds

8 in all activity
SambaNova

Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives

$1BSeries F
Role not disclosed
Anthropic

Develops Claude and conducts research into reliable, interpretable and steerable artificial intelligence.

$65BSeries H, includes prior hyperscaler commitments
Participant
Cyclic Materials

Recycles rare earth elements from end-of-life products and magnet production waste

$75MSeries C
Role not disclosed
Kailera Therapeutics

Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms.

$600MSeries B
Participant
PsiQuantum

PsiQuantum develops photonic quantum computing systems designed for fault-tolerant, utility-scale operation.

$1BSeries E
Participant
Anthropic

Develops Claude and conducts research into reliable, interpretable and steerable artificial intelligence.

$13BSeries F
Participant
Airtable

Airtable helps teams build applications, organise shared data and automate business workflows.

$735MSeries F
Participant